Clinical Research Directory

Inclusion Criteria: 1. Healthy child aged 4-11 years at time of enrollment, male or female 2. Not currently taking oral over-the-counter supplements or another multivitamin, if they are taking, must discontinue use for at least four weeks prior to randomization and for the duration of the study. 3. Parent reports active concern/challenge in behavior and selective eating confirmed by minimum threshold scores on three screening instruments: a. Selective Eating: \</= 3 on the Selective Eating Screening Tool Section A and at least two behavioral anchors Q11 = concern about child's nutrition "3-4 days per week or 5-7 days per week), Q12 = "fewer than 20 foods" (10-19 or fewer than 10), Q13 = refusal of ≥ 1 whole food group b. Behavior: Participants must meet both of the following criteria: 1. EDI Reactivity T-score ≥ 60 (for EDI or EDI-YC dependent on age of child); indicating elevated emotional reactivity relative to age-based norms (general population norms); -AND- 2. Behavioral Screening Tool: Evidence of clinically meaningful baseline difficulty in behavior and emotional regulation, defined as: ○ A rating of "Often" or "Very Often" (score ≥ 4) on all three Mood and Behavior Difficulties screening items; 4. Generally healthy as determined by caregiver report without any chronic medical condition that is unstable is actively being treated with medication changes, or that in the judgment of the Investigator would interfere with study participation or interpretation of results. 5. Parent is willing and able to administer the study product daily and complete questionnaires at all timepoints 6. Willing and able to maintain current diet, physical activity consistently throughout the study duration. 7. Parent is able to read and understand English. 8. Parent is able to read, understand, and provide informed consent. 9. Parent is able to use a personal smartphone device and download Chloe by People Science. 10. Able to receive shipment of the product at an address within the United States. 11. Parent is able to complete study assessments over the course of up to 20 weeks. Exclusion Criteria: Any potential participants who: 1. Parent does not have a personal smartphone, internet access, or is unwilling to download Chloe. 2. Child does not meet minimum threshold screening scores in two domains as specified in Inclusion Criteria 3 3. Concomitant Therapies: 1. Current use of stimulant medication, antipsychotics, or appetite-modifying medications that has been initiated or changed within 8 weeks prior to enrollment (stable, long-term use may be considered on a case-by-case basis with Investigator approval). 2. Current use of any medication, supplement, or herbal remedy specifically targeted at behavior or appetite that has been initiated or changed within 8 weeks prior to randomization, or that the caregiver is unwilling to keep stable and unchanged for the duration of the study 3. Participants receiving any investigational therapies or treatments within 30 days prior to randomization. 4. Caregiver intends to introduce any new medications, supplements, or herbal remedies targeting behavior or appetite during the study period. 4. Other Illnesses or Conditions: 1. Diagnosed psychiatric disorders including but not limited to major depressive disorder, bipolar disorder, psychotic disorders or severe anxiety requiring medication changes or intensive treatment 2. Hospitalization or significant acute illness within 3 months prior to randomization that, in the judgment of the Investigator, could affect study outcomes or participant safety. 3. Planned major surgery or invasive treatment during study duration that, in the judgment of the principal investigator, would interfere with study participation or interpretation of results. 5. Known allergies or hypersensitivities to any of the study or placebo product ingredients 6. Currently enrolled in another interventional research study or plans to enroll in any other interventional research study at any point during the study's duration a. Only one child per household may enroll in this research at a time 7. Are unlikely for any reason to be able to comply with the trial or considered unsuited for participation in the study by the Principal Investigator